SCHEMBL28080100

SCHEMBL28080100

C=CCOC(C#N)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL555929 0.74
SCHEMBL29119256 0.74
SCHEMBL5175685 0.73
SCHEMBL29119091 0.71 F7 (0.34)
SCHEMBL28651841 0.70
SCHEMBL14659137 0.69
SCHEMBL1446648 0.69
SCHEMBL5303308 0.69 MEN1 (0.40)
SCHEMBL29119186 0.69 FAAH (0.40)
SCHEMBL28859222 0.69 FAAH (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107108672-B Condensed five rings imdazole derivatives UCB生物制药私人有限公司 2019-11-08 CN disclosed
CN-109219608-A FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB生物制药私人有限公司 2019-01-15 CN disclosed
CN-105814048-B Fused tricyclic benzimidizole derivatives as TNF active regulators UCB生物制药私人有限公司 2018-03-27 CN disclosed
CN-107108672-A The five rings imdazole derivatives of fusion UCB生物制药私人有限公司 2017-08-29 CN disclosed
CN-105814048-A Fused tricyclic imidazole derivatives as modulators of TNF activity UCB生物制药私人有限公司 2016-07-27 CN disclosed